3 UK shares to buy before the ISA deadline

We have until the ISA deadline on 5 April to use up our 2021-22 allowance. We’ll either use it or lose it, but what shall I buy?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

One English pound placed on a graph to represent an economic down turn

Image source: Getty Images

If you haven’t paid in your full ISA allowance yet, you only have a few weeks left before you lose what’s left of it. Even if we can’t use the full £20,000, the ISA deadline can provide extra impetus for stashing away as much as we can.

That’s why I’ve built a list of shares to consider buying before the 5 April deadline. Today, I’m looking at three of them.

Insiders buying

One is Purplebricks (LSE: PURP). The online estate agent has been through its early growth boom and bust, and we’re looking at a 75% share price fall over the past 12 months. But people inside and close to the company have been buying heavily, and it’s been picking up strongly over the past couple of weeks.

What might push the Purplebricks share price higher? For the first half this year, the company recorded a disappointing operating loss. But its adjusted EBITDA loss was only small, and I’m hoping it can be overturned in the second half. If Purplebricks can turn a profit in the full year, I could see investors buying back in.

What are the risks? The big one, surely, is getting into the property business right now. Inflation is climbing, with energy prices through the roof. And interest rates are rising, making mortgages more expensive. But Purplebricks is still an ISA deadline candidate for me.

Buy oil?

BP (LSE: BP) has been on a white knuckle ride of late, with the hydrocarbon business falling out of favour. BP slumped when it announced its net zero ambitions. But the war in Ukraine and the shunning of Russian oil has shown just how dependent we still are on the black stuff.

The soaring oil price has strengthened the BP share price. With Saudi Arabia set to open the taps and boost world supply, that seems likely to drop back a bit. For now though, oil seems to be holding at around $100.

If I buy BP shares before the ISA deadline, I think my biggest risk is short-term uncertainty. BP is currently being driven, at least in part, by sentiment. And where the share price will land once the energy market stabilises again is anyone’s guess.

But I can’t help seeing BP shares as oversold in the rush to get away from those nasty hydrocarbons.

High-tech risk

I like the idea of a high-risk growth punt from time to time, with just a small amount of cash. So as my final possible investment choice before the ISA deadline, I’m looking at Darktrace (LSE: DARK).

The downsides? Well, the cybersecurity specialist has not turned a full-year profit yet. And it has attracted criticism from several observers who reckon they’re seeing too much style and not enough substance. Darktrace sponsors Formula One, so I can see what they mean. I’m not entirely convinced that’s the best way for a startup to be spending its money.

But the first half this year did bring a profit. And that gave the Darktrace share price a modest but welcome boost. Valuation metrics don’t make much sense in a turnaround year. But if this marks the start of growing profits for Darktrace, I can see the shares starting to look undervalued.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »